Revision history of "Innovative microbiological products" (Q104339)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

23 March 2024

15 January 2024

12 June 2023

24 May 2023

2 March 2023

27 October 2022

26 October 2022

21 October 2022

2 July 2022

  • curprev 12:4312:43, 2 July 2022DG Regio talk contribs 80,658 bytes +52,339 Changed label, description and/or aliases in da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et, nl, fr, de, it, es, and other parts: Adding translations: da, el, hr, ro, sk, mt, pt, fi, sl, cs, lt, lv, bg, hu, ga, sv, et,

18 January 2022

15 January 2022

17 December 2021

7 December 2021

1 December 2021

  • curprev 09:2009:20, 1 December 2021DG Regio talk contribs 16,728 bytes +2,910 Created claim: summary (P836): Les principaux objectifs du projet sont les suivants: I/commercialisation des travaux de recherche et développement réalisés par le département R & D de BioMaxima en lançant la production de produits nouveaux et améliorés: Suppléments, y compris: 1/Supplément de légionelle GVPC; 2/Supplément au CST; 3/Listeria Oxford Supplément modifié; 4/Salmonella Supplément. Substrat Lowenstein-JENSEN MEDIUM en deux versions: Lowenstein-Jensen Moyen + MG + su...
  • curprev 09:2009:20, 1 December 2021DG Regio talk contribs 13,818 bytes +94 Changed label, description and/or aliases in fr: translated_label

29 October 2020

17 October 2020

  • curprev 16:4716:47, 17 October 2020DG Regio talk contribs 14,163 bytes +94 Changed label, description and/or aliases in 1 language: translated_label
  • curprev 16:4716:47, 17 October 2020DG Regio talk contribs 14,069 bytes −88 Changed label, description and/or aliases in 1 language: remove_english_label
  • curprev 16:4716:47, 17 October 2020DG Regio talk contribs 14,157 bytes +2,605 Created claim: summary (P836): The main objectives of the project are: I/commercialisation of research and development work carried out by the BioMaxima R & D Department by launching the production of new and improved products: Supplements, including: 1/GVPC Legionella Supplement; 2/TSC Supplement; 3/Listteria Oxford Modified Supplement; 4/Salmonella Supplement. Lowenstein-JENSEN MEDIUM in two versions: Lowenstein-Jensen Medium + MG + Glycerol and antibiotics substrates: Lowe...
  • curprev 16:4716:47, 17 October 2020DG Regio talk contribs 11,552 bytes −2,177 Removed claim: summary (P836): The main objectives of the project are to: And/and/or commercialisation itself carried out by the BioMaxima Unit R BioMaxima R & D by launching the production of new and improved products: Supplements, including: 1/Suplement legionella GVPC; 2/TSC Supplement; 3/Listeria, Oxford Modified Supplement; 4/Salmonella Supplement. LOWENSTIN-JENSEN MEDIUM base in two versions: Lowenstein-Jensen Medium + MG + Glycesol and antibiotics containing antibiot...

23 September 2020

22 June 2020

10 June 2020

7 June 2020

26 March 2020

9 March 2020

  • curprev 09:1609:16, 9 March 2020DG Regio talk contribs 12,440 bytes +2,177 Created claim: summary (P836): The main objectives of the project are to: And/and/or commercialisation itself carried out by the BioMaxima Unit R BioMaxima R & D by launching the production of new and improved products: Supplements, including: 1/Suplement legionella GVPC; 2/TSC Supplement; 3/Listeria, Oxford Modified Supplement; 4/Salmonella Supplement. LOWENSTIN-JENSEN MEDIUM base in two versions: Lowenstein-Jensen Medium + MG + Glycesol and antibiotics containing antibiotic...

24 February 2020

18 February 2020

31 January 2020

14 January 2020